The global genomics market held US$ 18,964.2 Mn in 2020 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2025 to 2033. The exploration of genomics has surpassed in the last three decades to massive advancements in the technology that allowed the researchers to sequence larger pieces of genome.
The currently available techniques applied in surface disinfection are consistently improving to adapt to any environment. Conventional disinfection activities mainly aim to supplement healthcare facilities and improve healthcare system efficiency. As the overall emphasis on disinfection and maintaining sterile environment is advancing, the use of surfaces with inherent antimicrobial properties is being considered as a potential alternative to disinfection. However, the possible high cost of these items and distant availability have made the use of disinfectants imperative.
The travel vaccines market is set to reach US$ 9,068.9 Mn by 2033 from US$ 4730.3 Mn in 2021 showcasing steady growth at a compounded annual growth rate (CAGR) of 7.5% during the forecast period from 2025 to 2033. As per the research findings of World Tourism Organization (WTO) the number of international arrivals throughout the globe is expected to reach 1.6 billion by 2020.
The Contract Development and Manufacturing Organization (CDMO) industry had begun decades ago as a niche business by offering specialty services and manufacturing capacities to pharmaceutical companies. The advent of CDMOs was mainly attributed to the failures of pharmaceutical companies due to challenged competencies and financial constraints.
The global medical electrodes market accounted for a value of US$ 1,217.3 Mn in 2017, and expected to attain US$ 2,406.9 Mn by 2026. Factors characterizing the growth of this market are globally growing elder population base, along with increasing adoption of medical electrodes for the diagnosis and treatment of various conditions, technological advances in medical electrodes, and rising preference for minimally invasive procedures.
Global industrial heat exchangers market was valued at US$ 13,978.5 Mn in 2020 and set to grow at a CAGR of 7.6% throughout the forecast period from 2021 to 2029. Growing industrialization among developing countries noted as one of the prominent factors driving industrial heat exchangers market worldwide. Heat exchanger serves broad range of industry applications. Numerous industries including chemical, oil & gas, food & beverage, power generation along with HVAC and pulp & paper industry are increasingly adopting heat exchangers as a component of heating as well as cooling systems.
The human microbiome market is set to reach US$ 1,990.5 Mn by 2029 from US$ 840.1 Mn in 2020 at a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2021 to 2029. According to the research findings of World Health Organization (WHO), the burden associated with non-communicable diseases is set increase to 57% by 2020. The mortality rate related to chronic diseases will be more pronounced in the developing regions in comparison to the developed regions.
Dietary Fibers market is projected to reach US$ 11.35 Bn by 2029 with 11.1% CAGR during the forecast period from 2021 to 2029. In 2020, North America held the largest value and volume share in the global dietary fibers market and Asia Pacific is projected to be the fastest growing region between 2021 and 2029.
Organic acids market is projected to grow at 6.2% CAGR during the forecast period from 2021 to 2029. In 2020, Asia Pacific held the largest value and volume share in the global organic acids market and is projected to be the fastest-growing region between 2019 and 2029.
Body oils market projected to grow at a CAGR of 4.2% during the forecast period from 2021 to 2029. In 2020, Asia Pacific held the leading market share in terms of revenue. Body oils function as an emollient and an occlusive thus preventing cell cohesion and transepidermal water loss. It has essential ingredients such as vitamins, fatty acids, antioxidants, and polyphenols among others.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.